Cargando…
ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184782/ http://dx.doi.org/10.1016/S1569-1993(22)00320-4 |
| _version_ | 1784724603372830720 |
|---|---|
| author | Elborn, J.S. Jin, M. Douglass, J.A. Calhoun, W.J. Agarwal, R. Lazarewicz, S. Yan, M. |
| author_facet | Elborn, J.S. Jin, M. Douglass, J.A. Calhoun, W.J. Agarwal, R. Lazarewicz, S. Yan, M. |
| author_sort | Elborn, J.S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9184782 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91847822022-06-10 ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis Elborn, J.S. Jin, M. Douglass, J.A. Calhoun, W.J. Agarwal, R. Lazarewicz, S. Yan, M. J Cyst Fibros E-Poster Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184782/ http://dx.doi.org/10.1016/S1569-1993(22)00320-4 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | E-Poster Sessions Elborn, J.S. Jin, M. Douglass, J.A. Calhoun, W.J. Agarwal, R. Lazarewicz, S. Yan, M. ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title | ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title_full | ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title_fullStr | ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title_full_unstemmed | ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title_short | ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| title_sort | eps5.02 effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis |
| topic | E-Poster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184782/ http://dx.doi.org/10.1016/S1569-1993(22)00320-4 |
| work_keys_str_mv | AT elbornjs eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT jinm eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT douglassja eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT calhounwj eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT agarwalr eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT lazarewiczs eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis AT yanm eps502effectofomalizumabonglucocorticoiduseandlungfunctioninthetreatmentofallergicbronchopulmonaryaspergillosisinpeoplewithcysticfibrosisasystematicreviewandmetaanalysis |